Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study
Titel:
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study
Auteur:
Jabbour, Elias Short, Nicholas J Ravandi, Farhad Huang, Xuelin Daver, Naval DiNardo, Courtney D Konopleva, Marina Pemmaraju, Naveen Wierda, William Garcia-Manero, Guillermo Sasaki, Koji Cortes, Jorge Garris, Rebecca Khoury, Joseph D Jorgensen, Jeffrey Jain, Nitin Alvarez, Joie O'Brien, Susan Kantarjian, Hagop